Copertina

Underutilization of Injectable Parkinson's Disease Medication: An Analysis of Neurologist and Patient Perspectives

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Gianni Solis, Jordan Patierno, Josh Rossol, Rajeev Kumar
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Movement Disorders Clinical Practice
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Patient Perspectives on Upper‐Limb Daily Function in Parkinson's Disease
di: Noa Cohen, et al.
Pubblicazione: (2024)

Leucencephalopathy in Patients with Parkinson's Disease and Deep Brain Stimulation
di: Pawel Jarski, et al.
Pubblicazione: (2024)

Freezing of Gait in Parkinson's Disease: Don't Leave Patients in the Dark!
di: Franka Goossens, et al.
Pubblicazione: (2025)

Re‐Emergent Vocal Tremor in a Patient with Parkinson's Disease
di: Takeharu Tsuboi, et al.
Pubblicazione: (2025)

Clinical and Imaging Correlates of Medication Reduction in Globus Pallidus Stimulation for Parkinson's Disease
di: Daniel G. Di Luca, et al.
Pubblicazione: (2025)

Patient Experience and Feasibility of a Remote Monitoring System in Parkinson's Disease
di: Bart R. Maas, et al.
Pubblicazione: (2024)

Cognitive and Psychiatric Adverse Effects of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease
di: Sacha Brohée, et al.
Pubblicazione: (2025)

Reply: “Navigating the Neuropsychiatric Risks of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease”
di: Fabien Hauw, et al.
Pubblicazione: (2025)

Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to Relatives
di: Jeanine Schulze, et al.
Pubblicazione: (2024)

Randomized Observer‐Blind Study on the Effects of Neuromuscolar Taping in Parkinson's Disease Patients
di: Fabiana Giada Radicati, et al.
Pubblicazione: (2025)

Discrepant Views of Apathy in Patients and Caregivers: the Role of Cognitive Deficits in Parkinson's Disease
di: Giulia Funghi, et al.
Pubblicazione: (2025)

Artificial Intelligence Predicts GBA1 Mutated Status in Parkinson's Disease Patients
di: Giulia Di Rauso, et al.
Pubblicazione: (2025)

Patient‐Reported Communication Decline Following Deep Brain Stimulation in Parkinson's Disease
di: Stephanie M. Simone, et al.
Pubblicazione: (2026)

PARKinSOUND 2.0: Impact of Participation in an Orchestra in Patients with Parkinson's Disease
di: Sofia Lopes, et al.
Pubblicazione: (2026)

A Holistic Wellness Prescription for Parkinson's Disease: Evidence‐Based Perspectives and Unmet Needs
di: Indu Subramanian, et al.
Pubblicazione: (2025)

Changes in Gait Speed Vary Widely after the Use of Antiparkinson Medication in Persons with Parkinson's Disease
di: Anson B. Rosenfeldt, et al.
Pubblicazione: (2025)

Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease
di: Maria Teresa Pellecchia, et al.
Pubblicazione: (2025)

The Feasibility and Practical Utility of Virtual Visits for Patients with Parkinson's Disease in Different World Regions
di: Álvaro García‐Bustillo, et al.
Pubblicazione: (2025)

Letter to the Editor on “Cognitive and Psychiatric Adverse Effects of Foslevodopa/Foscarbidopa in Patients with Parkinson's Disease”
di: Bruno Bergmans, et al.
Pubblicazione: (2025)

Dopa Responsiveness in Parkinson's Disease
di: Sacha E. Gandhi, et al.
Pubblicazione: (2024)

Management of Anxiety in Parkinson's Disease
di: Alex J. Berry, et al.
Pubblicazione: (2025)

Levodopa Equivalent Daily Dosage: Geographical Variations and Real‐Life Modules in Parkinson's Disease
di: Prashanth Lingappa Kukkle, et al.
Pubblicazione: (2024)

Treatment‐Emergent Parkinsonism in Four Patients Treated with Chimeric Antigen Receptor T‐Cell Therapy
di: John B. Sanderson, et al.
Pubblicazione: (2025)

Exocrine Gland Dysfunction in Parkinson's Disease: Pathophysiology, Clinical Manifestations, and Therapeutic Perspectives—A Narrative Review
di: Renato P. Munhoz, et al.
Pubblicazione: (2026)

Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years
di: Sacha E. Gandhi, et al.
Pubblicazione: (2024)

Levodopa/Carbidopa Intestinal Gel ( LCIG ) Treatment in a Patient with Parkinson's Disease and Hemophilia A
di: Petra Havránková, et al.
Pubblicazione: (2026)

Correction to “The Prevalence of Parkinson Disease in Ukraine”
Pubblicazione: (2024)

Mouth Motor Overflow in Parkinson's Disease
di: Karim Makhoul, et al.
Pubblicazione: (2026)

An Unusual Motor OFF in Parkinson's Disease
di: Shreyashi Jha, et al.
Pubblicazione: (2025)

Enteral Nutrition in Idiopathic Parkinson's Disease and Atypical Parkinsonism: A Systematic Review
di: Bradley Lonergan, et al.
Pubblicazione: (2026)

Novel Interdisciplinary Gastroenterology and Parkinson's Disease Clinic in a Parkinson's Center of Excellence
di: Monica Arena, et al.
Pubblicazione: (2025)

Characterizing Hand Function in Parkinson's Disease Patients with a Self‐Administered Electronic Manual Dexterity Test
di: A. Elizabeth Jansen, et al.
Pubblicazione: (2024)

Apomorphine Subcutaneous Infusion Likely Induced Acute Thrombocytopenia in a Patient with Parkinson's Disease and Motor Fluctuations
di: Maria Magdalena Pocora, et al.
Pubblicazione: (2024)

Brain Imaging Changes Following Deep Brain Stimulation Patients with Parkinson's Disease: A Literature Review
di: Suraiya Mangra, et al.
Pubblicazione: (2025)

Current Perspectives and Practices in Infection‐Related Movement Disorders ( IRMD ): Insights from a Survey of Members of the International Parkinson and Movement Disorder Society
di: Divyani Garg, et al.
Pubblicazione: (2025)

Does Delaying Levodopa Prevent Motor Complications in Parkinson's Disease? A Meta‐Analysis
di: Luis Guilherme Ramanzini, et al.
Pubblicazione: (2024)

Glymphatic Dysfunction in Parkinson's Disease: A Systematic Review and Meta‐Analysis of Neuroimaging Studies
di: Shahryar Rajai Firouzabadi, et al.
Pubblicazione: (2025)

Computer Vision Analysis for Objective Motor Assessment in Parkinson's Disease: A Retrospective Study
di: Pasquale Maria Pecoraro, et al.
Pubblicazione: (2025)

Prodromal Peripheral Immune Cell Profile in Drug‐Induced Parkinsonism Relative to Parkinson's Disease
di: Brandon Lien, et al.
Pubblicazione: (2025)

Racial and Ethnic Diversity in Clinical Trials for Disease Modifying Drugs in Parkinson Disease: A Systematic Review & Meta‐Analysis
di: Farley Reis Rodrigues, et al.
Pubblicazione: (2025)